Mes: marzo 2022

CAAB Vax meets Johnson & Johnson/Janssen to clarify doubts on its covid-19 vaccine

Last November 15, a group of advocates working on vaccine access issues met with representatives of Johnson & Johnson (J&J)/Janssen to discuss issues related to the company’s mono-dose vaccine, popularly known as the Janssen Adeno26 COVID vaccine. The meeting was an opportunity for advocates to pose questions dealing with the safety issues, dosage, the current …

CAAB Vax meets Johnson & Johnson/Janssen to clarify doubts on its covid-19 vaccine Leer más »